als

Drug Name: Relyvrio Active Ingredient: sodium phenylbutyrate/taurursodiol Indications: To treat amyotrophic lateral sclerosis (ALS) Approval Date: 9/29/2022 Company: Amylyx Pharmaceuticals, Inc Learn more:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216660s000lbledt.pdf